CRO News

Breaking News | CRO News | Industry News | Promotions & Moves

BioAgilytix Names Two New Scientific Officers

Lynn Kamen and Michelle Miller offer over two decades of experience combined in drug discovery, development and immunology and toxicology.

05.10.22

Breaking News | CRO News

Novotech Acquires U.S. CRO NCGS

Can now offer its biotech clients clinical services in the U.S. to support later phase global studies.

05.05.22

Biologics, Proteins, Vaccines | Breaking News | CRO News

Avance Biosciences Validates 26,000 Square Feet of New Laboratory Space

Also expands its mammalian cell culture related assay capabilities.

05.05.22

Breaking News | CRO News | Industry News

Symeres Acquires Organix

Adds lipids expertise and a foothold in the U.S.

05.02.22

Agilex Biolabs Expands U.S. Presence

Doubles in size with launch of new large molecule facility.

04.13.22

Breaking News | CRO News | Facilities

Charnwood Molecular Opens New Facilities in Loughborough

Quadruples the company’s capacity and greatly expands its capabilities.

04.08.22

Breaking News | CRO News | Preclinical Outsourcing

Charles River Acquires Explora BioLabs for $295M

Explora BioLabs operates 15 preclinical vivarium facilities, offering rental space in the Southern California, San Francisco, and Boston-Cambridge biohubs.

04.06.22

Breaking News | CRO News

WCG Launches CRO Strategic Alliance Program

Enables CROs to better serve patients and research sponsors, and accelerate the pace at which new therapies are brought to market.

04.06.22

Breaking News | CRO News

Celerion Invests in ADME Suite of Services

Expands laboratory space, and adds new capabilities as well as a dedicated customer service team.

04.06.22

Breaking News | CRO News

Calyx Selected as Approved Partner by ProTrials Research

Calyx will extend its solutions and services to help ProTrials’ customers achieve their clinical development objectives.

03.21.22

Breaking News | Clinical Trials | CRO News | Drug Development | Information Technology

Emmes Acquires CRO Casimir

Expands rare and orphan disease clinical research and drug development capabilities.

03.11.22

Celerion Expands Early Phase Clinical Pharmacology Units

Adds new Screening and Return Center, upgraded pharmacy compounding suites, expanded ADME lab capacity and fifty additional beds.

03.09.22

Flow Eighteen38 Expands Production and Biophysical Capabilities

Investment of $5.5mn supports expansion of services to include pre-CMC stages for faster and successful biotherapeutics development.

03.08.22

Breaking News | Collaborations & Alliances | CRO News | Drug Discovery | Industry News

Orbit Discovery and WuXi AppTec Enter Discovery Alliance

Sign agreement to access peptide discovery and optimization technologies.

03.08.22

Breaking News | Clinical Trials | Collaborations & Alliances | CRO News | Drug Development

IQVIA, Argenx Partner to Accelerate Clinical Development of VYVGART

Collaboration to support clinical development, regulatory, commercial and real-world evidence to accelerate the development of new indications for VYVGART.

03.01.22